|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1998-2-12
|
|
pubmed:abstractText |
A new commercial glycoprotein G-based enzyme immunoassay (gG-EIA) was compared with Western blotting (WB) for detection of herpes simplex virus type 1 (HSV-1) or HSV-2 type-specific antibodies in 193 serum samples. Sensitivity for HSV-1 was 95%; specificity was 96%. Sensitivity for HSV-2 was 98%; specificity was 97%. Twelve of 13 serum samples with equivocal gG-EIA results were serotyped by WB.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-1316370,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-1457634,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-1652909,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-2163115,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-2541645,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-2543928,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-2835389,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-2988143,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-3012335,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-3033506,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-3034759,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-6253866,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-7503497,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-7643884,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-8387628,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-9262493,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9431971-9389945
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0095-1137
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
294-5
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies.
|
|
pubmed:affiliation |
Department of Laboratory Medicine, University of Washington, Seattle, USA. rashley@u.washington.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
